More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$68595663
EPS
-0.15
P/E ratio
--
Price to sales
--
Dividend yield
--
Beta
1.237997
Previous close
$0.82
Today's open
$0.83
Day's range
$0.71 - $0.84
52 week range
$0.71 - $5.36
CEO
Terrie Kellmeyer
Employees
34
Headquarters
New York, NY
Exchange
Nasdaq Global Select
Shares outstanding
92696842
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
ANAVEX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important November 30 Deadline in Securities Class Action First Filed by the Firm – AVXL
NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
GlobeNewsWire • an hour ago

Kaplan Fox Advises Investors of Anavex Life Sciences Corp. (AVXL) of an Upcoming Securities Class Action Deadline on November 30, 2026
New York, New York--(Newsfile Corp. - November 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Anavex and have suffered losses, you may CLICK HERE to contact us.
Newsfile Corp • 9 hours ago

AVXL EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Anavex (AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 18, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Newsfile Corp • 5 hours ago

DEADLINE ALERT for Fluence Energy, Inc. (FLNC), Qfin Holdings, Inc. (QFIN), Endava plc (DAVA), and Anavex Life Sciences Corp. (AVXL): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions
Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions
GlobeNewsWire • 3 hours ago

Anavex Life Sciences, Corp. (NASDAQ: AVXL) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Anavex Life Sciences, Corp. Securities Lawsuit - Contact Portnoy Law Firm
LOS ANGELES, Nov. 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Anavex Life Sciences, Corp. (NASDAQ: AVXL) that a securities class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Anavex common stock between November 26, 2025 and August 28, 2026, inclusive (the 'Class Period'). Find out if you qualify to recover your per-share losses by choosing to join the class action and submit your trade details . Investors who suffered financial losses have until November 30, 2026 to seek appointment as lead plaintiff. Shareholders should contact Lesley Portnoy via e-mail (Lesley@portnoylaw.com or call (310) 692-8883) or visit http://portnoylaw.com/anavex-life-sciences-corp to learn more information and discuss their legal rights.
GlobeNewsWire • Nov 17, 2026

Deadline Alert: Anavex Life Sciences Corp. Investors Have Until November 30, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors
Class action covers investors who bought Anavex Life Sciences Corp. securities between November 26, 2025 and August 28, 2026; complaint alleges the company failed to disclose material adverse facts Class action covers investors who bought Anavex Life Sciences Corp. securities between November 26, 2025 and August 28, 2026; complaint alleges the company failed to disclose material adverse facts
GlobeNewsWire • Nov 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines – AVXL
NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
GlobeNewsWire • 20 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor Harm
New York, New York--(Newsfile Corp. - November 17, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period").
Newsfile Corp • Nov 17, 2026

AVXL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 30 Deadline in Securities Class Action First Filed by the Firm - AVXL
New York, New York--(Newsfile Corp. - November 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Newsfile Corp • Nov 17, 2026

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Anavex Life Sciences Corp. (NASDAQ: AVXL) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: November 30, 2026. Investors who purchased (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 may be eligible to recover losses.
GlobeNewsWire • Nov 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Anavex Life Sciences Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.